693 related articles for article (PubMed ID: 11694206)
61. Individual differences in responses to the first cigarette following overnight abstinence in regular smokers.
Niaura R; Shadel WG; Goldstein MG; Hutchinson KE; Abrams DB
Nicotine Tob Res; 2001 Feb; 3(1):37-44. PubMed ID: 11260809
[TBL] [Abstract][Full Text] [Related]
62. Nicotine-mecamylamine interactions.
Zevin S; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
[TBL] [Abstract][Full Text] [Related]
63. [The nicotine patch. Short-term results in a group of hospital workers].
Jiménez Ruiz CA; Solano Reina S; Flórez S; Ramos A; Ramos L
Rev Clin Esp; 1994 Jun; 194(6):477-9. PubMed ID: 8079018
[TBL] [Abstract][Full Text] [Related]
64. Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse.
Gold MS; Herkov MJ
J Addict Dis; 1998; 17(1):7-21. PubMed ID: 9549599
[No Abstract] [Full Text] [Related]
65. Biological aspects of the link between smoking and depression.
Quattrocki E; Baird A; Yurgelun-Todd D
Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935
[TBL] [Abstract][Full Text] [Related]
66. Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type.
Lewis AJ; Truman P; Hosking MR; Miller JH
Tob Control; 2012 Jan; 21(1):39-43. PubMed ID: 21636610
[TBL] [Abstract][Full Text] [Related]
67. [Drug aid to tobacco withdrawal].
Bobrie G; Battaglia C; Loufrani E; Ménard J
Rev Prat; 1993 May; 43(10):1238-44. PubMed ID: 8235362
[TBL] [Abstract][Full Text] [Related]
68. Pharmacotherapy for smoking cessation.
Nunn-Thompson CL; Simon PA
Clin Pharm; 1989 Oct; 8(10):710-20. PubMed ID: 2680239
[TBL] [Abstract][Full Text] [Related]
69. Disrupting nicotine reinforcement: from cigarette to brain.
Rose JE
Ann N Y Acad Sci; 2008 Oct; 1141():233-56. PubMed ID: 18991961
[TBL] [Abstract][Full Text] [Related]
70. Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking.
Bacher I; Houle S; Xu X; Zawertailo L; Soliman A; Wilson AA; Selby P; George TP; Sacher J; Miler L; Kish SJ; Rusjan P; Meyer JH
Arch Gen Psychiatry; 2011 Aug; 68(8):817-26. PubMed ID: 21810646
[TBL] [Abstract][Full Text] [Related]
71. Withdrawal from nicotine dependence using mecamylamine: comparison of three-week and six-week dosage schedules.
Tennant FS; Tarver AL
NIDA Res Monogr; 1984; 55():291-7. PubMed ID: 6443388
[TBL] [Abstract][Full Text] [Related]
72. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.
McKee SA; Weinberger AH; Harrison EL; Coppola S; George TP
Schizophr Res; 2009 Dec; 115(2-3):317-24. PubMed ID: 19700263
[TBL] [Abstract][Full Text] [Related]
73. Silver acetate interactions with nicotine and non-nicotine smoke components.
Rose JE; Behm FM; Murugesan T; McClernon FJ
Exp Clin Psychopharmacol; 2010 Dec; 18(6):462-9. PubMed ID: 21186921
[TBL] [Abstract][Full Text] [Related]
74. Emergence of depression during early abstinence in depressed and non-depressed women smokers.
Pomerleau CS; Brouwer RJ; Pomerleau OF
J Addict Dis; 2001; 20(1):73-80. PubMed ID: 11286432
[TBL] [Abstract][Full Text] [Related]
75. A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers.
Glover ED; Laflin MT; Schuh KJ; Schuh LM; Nides M; Christen AG; Glover PN; Strnad JV
Addiction; 2007 May; 102(5):795-802. PubMed ID: 17506156
[TBL] [Abstract][Full Text] [Related]
76. Anxiety and smoking cessation outcomes in alcohol-dependent smokers.
Kelly MM; Grant C; Cooper S; Cooney JL
Nicotine Tob Res; 2013 Feb; 15(2):364-75. PubMed ID: 22955245
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
Mattioli L; Perfumi M
J Psychopharmacol; 2011 Mar; 25(3):402-10. PubMed ID: 19939867
[TBL] [Abstract][Full Text] [Related]
78. Distinguishing risk factors for the onset of cravings, withdrawal symptoms and tolerance in novice adolescent smokers.
Wileyto P; O'Loughlin J; Lagerlund M; Meshefedjian G; Dugas E; Gervais A
Tob Control; 2009 Oct; 18(5):387-92. PubMed ID: 19648131
[TBL] [Abstract][Full Text] [Related]
79. Smoking cessation outcomes and predictors among individuals with co-occurring substance use and/or psychiatric disorders.
Okoli CT; Khara M
J Dual Diagn; 2014; 10(1):9-18. PubMed ID: 25392058
[TBL] [Abstract][Full Text] [Related]
80. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
Paterson NE; Markou A
Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
